Cas:1187385-63-2 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole manufacturer & supplier

Chemical Name:2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole

CAS.NO:1187385-63-2

Synonyms:2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole

Molecular Formula:C₁₃H₈BrN₃O

Molecular Weight:302.12600

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:51.81000

Exact Mass:300.98500

LogP:3.56110

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole Use and application,2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole technical grade,usp/ep/jp grade.

Related News: Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole manufacturer Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole supplier Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole vendor Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole factory The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting.